These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 35492399)
1. Tumor-infiltrating T-regulatory cells adapt to altered metabolism to promote tumor-immune escape. Sarkar T; Dhar S; Sa G Curr Res Immunol; 2021; 2():132-141. PubMed ID: 35492399 [TBL] [Abstract][Full Text] [Related]
2. Tumor-Infiltrating Regulatory T-cell Accumulation in the Tumor Microenvironment Is Mediated by IL33/ST2 Signaling. Son J; Cho JW; Park HJ; Moon J; Park S; Lee H; Lee J; Kim G; Park SM; Lira SA; Mckenzie AN; Kim HY; Choi CY; Lim YT; Park SY; Kim HR; Park SH; Shin EC; Lee I; Ha SJ Cancer Immunol Res; 2020 Nov; 8(11):1393-1406. PubMed ID: 32878747 [TBL] [Abstract][Full Text] [Related]
3. <Editors' Choice> Meddling with meddlers: curbing regulatory T cells and augmenting antitumor immunity. Kochin V; Nishikawa H Nagoya J Med Sci; 2019 Feb; 81(1):1-18. PubMed ID: 30962651 [TBL] [Abstract][Full Text] [Related]
4. FoxP3 Saleh R; Elkord E Cancer Lett; 2020 Oct; 490():174-185. PubMed ID: 32721551 [TBL] [Abstract][Full Text] [Related]
5. INFα-2b inhibitory effects on CD4(+)CD25(+)FOXP3(+) regulatory T cells in the tumor microenvironment of C57BL/6 J mice with melanoma xenografts. Yu Y; Huang R; Zong X; He X; Mo W BMC Cancer; 2016 Jul; 16():397. PubMed ID: 27389040 [TBL] [Abstract][Full Text] [Related]
6. Contribution of regulatory T cells to cancer: A review. Najafi M; Farhood B; Mortezaee K J Cell Physiol; 2019 Jun; 234(6):7983-7993. PubMed ID: 30317612 [TBL] [Abstract][Full Text] [Related]
7. IL-33 in the tumor microenvironment is associated with the accumulation of FoxP3-positive regulatory T cells in human esophageal carcinomas. Cui G; Li Z; Ren J; Yuan A Virchows Arch; 2019 Nov; 475(5):579-586. PubMed ID: 31062086 [TBL] [Abstract][Full Text] [Related]
8. Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B. Gao Y; You M; Fu J; Tian M; Zhong X; Du C; Hong Z; Zhu Z; Liu J; Markowitz GJ; Wang FS; Yang P J Hepatol; 2022 Jan; 76(1):148-159. PubMed ID: 34689996 [TBL] [Abstract][Full Text] [Related]
9. Correlations between Circulating and Tumor-Infiltrating CD4 Al-Mterin MA; Murshed K; Elkord E Vaccines (Basel); 2022 Mar; 10(4):. PubMed ID: 35455287 [TBL] [Abstract][Full Text] [Related]
10. Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells. Sasidharan Nair V; Elkord E Immunol Cell Biol; 2018 Jan; 96(1):21-33. PubMed ID: 29359507 [TBL] [Abstract][Full Text] [Related]
11. Qntrolling the LncRNA HULC-Tregs-PD-1 axis inhibits immune escape in the tumor microenvironment. Wang X; Mo X; Yang Z; Zhao C Heliyon; 2024 Apr; 10(7):e28386. PubMed ID: 38560250 [TBL] [Abstract][Full Text] [Related]
12. Methionine enkephalin (MENK) inhibits tumor growth through regulating CD4+Foxp3+ regulatory T cells (Tregs) in mice. Li X; Meng Y; Plotnikoff NP; Youkilis G; Griffin N; Wang E; Lu C; Shan F Cancer Biol Ther; 2015; 16(3):450-9. PubMed ID: 25701137 [TBL] [Abstract][Full Text] [Related]
13. Human FOXP3 and tumour microenvironment. Wang J; Gong R; Zhao C; Lei K; Sun X; Ren H Immunology; 2023 Feb; 168(2):248-255. PubMed ID: 35689826 [TBL] [Abstract][Full Text] [Related]
14. Expression of costimulatory and inhibitory receptors in FoxP3 Toker A; Ohashi PS Adv Cancer Res; 2019; 144():193-261. PubMed ID: 31349899 [TBL] [Abstract][Full Text] [Related]
16. PTEN-deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells. Vidotto T; Saggioro FP; Jamaspishvili T; Chesca DL; Picanço de Albuquerque CG; Reis RB; Graham CH; Berman DM; Siemens DR; Squire JA; Koti M Prostate; 2019 Jun; 79(9):969-979. PubMed ID: 30999388 [TBL] [Abstract][Full Text] [Related]
17. Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer. Revenko A; Carnevalli LS; Sinclair C; Johnson B; Peter A; Taylor M; Hettrick L; Chapman M; Klein S; Solanki A; Gattis D; Watt A; Hughes AM; Magiera L; Kar G; Ireland L; Mele DA; Sah V; Singh M; Walton J; Mairesse M; King M; Edbrooke M; Lyne P; Barry ST; Fawell S; Goldberg FW; MacLeod AR J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35387780 [TBL] [Abstract][Full Text] [Related]
18. Regulatory T Cells: Barriers of Immune Infiltration Into the Tumor Microenvironment. Scott EN; Gocher AM; Workman CJ; Vignali DAA Front Immunol; 2021; 12():702726. PubMed ID: 34177968 [TBL] [Abstract][Full Text] [Related]
19. The heterogeneous immune microenvironment in breast cancer is affected by hypoxia-related genes. Duechler M; Peczek L; Zuk K; Zalesna I; Jeziorski A; Czyz M Immunobiology; 2014 Feb; 219(2):158-65. PubMed ID: 24091277 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies. Nishikawa H; Koyama S J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34330764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]